microRNA‐1‐3p and T‐synthase mRNA have high diagnostic efficacy on intestinal mucosal barrier dysfunction in patients with severe acute pancreatitis

Abstract

Abstract Acute pancreatitis (AP) is an inflammatory disorder of the pancreas that can be complicated by intestinal mucosal barrier dysfunction (SAP&IBD). The current study sought to examine the diagnostic efficacy of miR‐1‐3p and T‐synthase mRNA in SAP&IBD patients. First, SAP patients were assigned to SAP&IBD and SAP groups. Serum miR‐1‐3p expression and T‐synthase mRNA expression patterns in peripheral blood B lymphocytes were measured using RT‐qPCR. Pearson tests, ROC curve analysis, and multivariate logistic regression were used to analyze the correlation between miR‐1‐3p/T‐synthase mRNA and clinical data, their diagnostic efficiency, and independent risk factors for SAP&IBD patients, respectively. The results showed that serum miR‐1‐3p in the SAP&IBD group was elevated, and T‐synthase mRNA expression in peripheral blood B lymphocytes was diminished. Additionally, serum miR‐1‐3p expression in SAP&IBD patients was negatively correlated with T‐synthase mRNA expression, and positively correlated with their Ranson score, CRP, IL‐6, DAO, and D‐Lactate levels. Meanwhile, T‐synthase mRNA level was negatively correlated with IL‐6, DAO, and D‐Lactate levels. Both, serum miR‐1‐3p, T‐synthase mRNA, and their combination were found to exhibit diagnostic efficiency for SAP&IBD patients, and were independently associated with IBD in SAP patients. Collectively, our findings suggest that miR‐1‐3p and T‐synthase serve as independent risk factors for SAP&IBD patients and can aid the diagnosis of IBD in SAP patients.

Keywords

• diagnosis
• intestinal mucosal barrier dysfunction
• microRNA‐1‐3p
• severe acute pancreatitis
• T‐synthase